Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Preethi Gopalakrishnan Nair

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Oncoimmunology|September 17, 2024
Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacyVishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, Shashi Gujar
ACS Nano|May 8, 2026
Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic ReprogrammingPreethi Gopalakrishnan Nair, Unnikrishnan Babukuttan Sheela, Vishnu Vijay Vijayan, et al.
Seminars in Immunology|May 18, 2026
Dendritic cells as central coordinators of oncolytic virus-induced antitumor immunityEhab M Ezzaldeen, Vishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, et al.
Mikrochimica Acta|March 28, 2020
Polysaccharide enabled biogenic fabrication of pH sensing fluorescent gold nanoclusters as a biocompatible tumor imaging probeShiji Raju, Manu Manalel Joseph, Raveendran Pillai Kuttanpillai, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directionsShashi Gujar, Jonathan G Pol, Vishnu Vijay Vijayan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Oncoimmunology|September 17, 2024
Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacyVishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, Shashi Gujar
ACS Nano|May 8, 2026
Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic ReprogrammingPreethi Gopalakrishnan Nair, Unnikrishnan Babukuttan Sheela, Vishnu Vijay Vijayan, et al.
Seminars in Immunology|May 18, 2026
Dendritic cells as central coordinators of oncolytic virus-induced antitumor immunityEhab M Ezzaldeen, Vishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, et al.
Mikrochimica Acta|March 28, 2020
Polysaccharide enabled biogenic fabrication of pH sensing fluorescent gold nanoclusters as a biocompatible tumor imaging probeShiji Raju, Manu Manalel Joseph, Raveendran Pillai Kuttanpillai, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directionsShashi Gujar, Jonathan G Pol, Vishnu Vijay Vijayan, et al.
Pageof 1